Core Laboratories (CLB) Tops Q3 EPS by 2c

Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.18, $0.02 better than the analyst estimate of $0.16. Revenue for the quarter came in at $118 million versus the consensus estimate of $104.77 million.

GUIDANCE:

Core Laboratories sees Q4 2021 EPS of $0.18-$0.22, versus the consensus of $0.19. Core Laboratories sees Q4 2021 revenue of $121-124 million, versus the consensus of $108 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Jefferies Starts Oversea-Chinese Banking Corp Ltd (OCBC:SP) (OVCHF) at Hold
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk